Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Carfilzomib well tolerated in consecutive-day schedule in hematologic malignancies

Dec. 13, 2007

SymBio initiates phase II clinical study of bendamustine hydrochloride

Dec. 12, 2007

Serenex initiates phase I trial of SNX-5422 for hematological malignancies

Dec. 12, 2007

Mologen submits clinical study application for dSLIM for the treatment of cancer

Dec. 12, 2007

Preclinical activity of OT-304 against chemotherapy-resistant tumors

Dec. 12, 2007

Bcr-Abl(T315I) drug-resistant clones are fully suppressed by combination therapy

Dec. 12, 2007

Novel oncolytic drugs covered in recent patents

Dec. 11, 2007

Metastatix initiates phase I clinical trial of MSX-122 for late-stage solid tumors

Dec. 11, 2007

Vion initiates Cloretazine trials in combination with stem cell transplantation

Dec. 11, 2007

EntreMed initiates phase II study with MKC-1 in pancreatic cancer

Dec. 11, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...